Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy - Wikidata - awgldk - TriplyDB

Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy

Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy

http://www.wikidata.org/entity/Q34501788

about

Immunoprofile from tissue microarrays to stratify familial breast cancer patients The Value of 18F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis.Expression and Clinical Significance of Claudin-7, PDL-1, PTEN, c-Kit, c-Met, c-Myc, ALK, CK5/6, CK17, p53, EGFR, Ki67, p63 in Triple-negative Breast Cancer-A Single Centre Prospective Observational Study.Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessment

P2860

Q36413928-F72179B3-F2D2-47B8-905C-69441E0487FC Q36653693-84A753D6-6243-4AC1-A154-B22CBAB52EF2 Q49486164-2E6F6070-788E-44D1-9595-617C3BC257EF Q55278765-AE304E3A-7F35-4DAD-B1B2-7749900A2F44 Q58698990-156F8CB2-F416-4457-B5DC-AEB4A77D9BEA

P2860

Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy

http://www.wikidata.org/entity/Q34501788

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Prognostic value of Ki67 expre ...... after neoadjuvant chemotherapy

@ast

Prognostic value of Ki67 expre ...... after neoadjuvant chemotherapy

@en

Prognostic value of Ki67 expre ...... after neoadjuvant chemotherapy

@nl

type

label

Prognostic value of Ki67 expre ...... after neoadjuvant chemotherapy

@ast

Prognostic value of Ki67 expre ...... after neoadjuvant chemotherapy

@en

Prognostic value of Ki67 expre ...... after neoadjuvant chemotherapy

@nl

prefLabel

Prognostic value of Ki67 expre ...... after neoadjuvant chemotherapy

@ast

Prognostic value of Ki67 expre ...... after neoadjuvant chemotherapy

@en

Prognostic value of Ki67 expre ...... after neoadjuvant chemotherapy

@nl

P1433

Q34501788-2309F830-D112-4259-B036-7D6DB8997F82

P1476

Q34501788-28F2736D-A01D-4288-A6B3-FE81F749C834

P2093

Q34501788-1A90A4FE-D69D-408D-B38B-FAC83FCB9AFA

Q34501788-76FC2C11-82A4-4C7D-B796-915299988836

Q34501788-B2D7AAF1-A61C-4700-8422-6B251FAD953E

Q34501788-E94A4605-999E-4633-A5FC-2062C6D6EE3C

Q34501788-F6D093C5-08EA-4FF6-946B-8BF0DC595755

P2860

Q34501788-01A8A05A-84A0-47A0-9B49-A41B4A5BC6E3

Q34501788-1E064C93-DA68-46E3-9368-70D941116F13

Q34501788-2FEB29AC-00BF-448A-818D-501CF45B85FC

Q34501788-3B702007-4639-4C21-A477-D1363C53D3C7

Q34501788-3CDD4843-1EB2-49F8-A5BB-B11BD811C9C0

Q34501788-4075C2AE-1F5B-4E0C-B193-1DB8D50A2BDD

Q34501788-40AC8EBF-CE9A-45A1-A091-5A5123094A29

Q34501788-4E745889-E6BB-4C2B-AF7D-78F7190C7AF4

Q34501788-68D85642-E6B8-4A3A-A572-2CE6E09E5233

Q34501788-6E08CB3B-6012-4CAC-978D-16F8391485D7

P304

Q34501788-418F628B-5EC7-46E0-8482-3FD98246B224

P31

Q34501788-14DE2851-6798-47AE-8036-302677AD2DA6

P433

Q34501788-F200E849-7274-42B7-BBC7-0D4B401B0EBE

P478

Q34501788-BF3D5C3C-8E10-40C2-A117-1EECFDDF551F

P577

Q34501788-F2EBE115-8252-455E-96A6-69099121C884

P698

Q34501788-DE465C06-4BC5-4449-B869-5370D3CF21A0

P921

Q34501788-E49CC6F3-C7C6-4D91-B724-40F914ED4891

P932

Q34501788-A0B992C9-A166-4A35-A8C8-D42DBFD367B1

P1433

International Journal of Clinical and Experimental Pathology

P1476

Prognostic value of Ki67 expre ...... after neoadjuvant chemotherapy

@en

P2093

Chang-Yuan Wei

http://www.w3.org/2001/XMLSchema#string

Qi-Xing Tan

http://www.w3.org/2001/XMLSchema#string

Qin-Guo Mo

http://www.w3.org/2001/XMLSchema#string

Qing-Hong Qin

http://www.w3.org/2001/XMLSchema#string

Wei-Ping Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer.

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment.

Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67.

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.

Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas.

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.

Ki67 in breast cancer: prognostic and predictive potential.

Use of standard markers and incorporation of molecular markers into breast cancer therapy: Consensus recommendations from an International Expert Panel.

P304

6862-6870

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25400769

http://www.w3.org/2001/XMLSchema#string

P921

P932

4230098

http://www.w3.org/2001/XMLSchema#string